See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2018_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 285,211,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,250,000 |
| 3 | remainder_Assets | 1,238,000 |
| 4 | LiabilitiesCurrent | 20,902,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,952,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 43,237,816 |
| 9 | ResearchAndDevelopmentExpense | 104,620,122 |
| 10 | remainder_Expenses | 7,616,075 |
| 11 | remainder_Revenues | 268,525 |
| 12 | remainder_NetIncome | 202,360 |
| 13 | remainder_ComprehensiveNetIncome | 52,070 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 295,699,000 |
| 1 | Liabilities | 26,854,000 |
| 2 | Expenses | 155,474,013 |
| 3 | Revenues | 268,525 |
| 4 | StockholdersEquity | 268,845,000 |
| 5 | NetIncome | -155,003,128 |
| 6 | ComprehensiveNetIncome | -154,977,093 |
| 7 | BaseVar | 239,274,984 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.67 |
| 9 | EconomicCapitalRatio | 3.47 |
Edgar->Model Mapping
Feature Distribution
Change over Time
